APOE and atherosclerosis: To assess the anti‐inflammatory effects of AVE0991 during the early stages of atherosclerosis, we focused on characterization of vascular and perivascular immune cells between the 16th and the 24th week of age in chow‐fed ApoE‐/‐ mice.